Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Manthorpe

Showing results (81-90 of 166) with videos related to

Pageof 17
Sort By:
Acta Pathologica, Microbiologica, Et Immunologica Scandinavica. Section C, Immunology|February 1, 1983
Autoantibodies in patients with oral lupus erythematosus, lichen planus and leukoplakia. An aid in diagnosisM Schiødt, H Permin, A Wiik, et al.
Acta Ophthalmologica|August 1, 1984
Mucosolvan in the treatment of patients with primary Sjögren's syndrome. Results from a double-blind cross-over investigationR Manthorpe, S H Petersen, J U Prause
Acta Pathologica, Microbiologica, Et Immunologica Scandinavica. Section A, Pathology|March 1, 1985
Langerhans cells in labial minor salivary glands in primary Sjögren's syndromeP Oxholm, R Manthorpe, A Oxholm, et al.
Scandinavian Journal of Rheumatology. Supplement|January 1, 1986
Impaired indomethacin-boosting of the defective natural killer cell activity in patients with primary Sjögren's syndromeB K Pedersen, P Oxholm, R Manthorpe, et al.
Scandinavian Journal of Rheumatology. Supplement|January 1, 1986
Erythrocyte complement C3b receptor (CR1) levels and immune complex-induced manifestations in patients with primary Sjögren's syndromeB S Thomsen, P Oxholm, H Nielsen, et al.
Arthritis and Rheumatism|August 1, 1987
Sjögren's syndrome: comments on the proposed criteria for classificationR Manthorpe, P Oxholm, J N Prause, et al.
Autoimmunity|January 1, 1993
Complement activation in patients with primary Sjögren's syndrome: an indicator of systemic diseaseS Lindgren, B Hansen, A G Sjöholm, et al.
Clinical and Experimental Immunology|January 1, 1986
Interleukin 2 augmentation of the defective natural killer cell activity in patients with primary Sjögren's syndromeB K Pedersen, P Oxholm, R Manthorpe, et al.
Scandinavian Journal of Rheumatology|January 1, 1986
Patients with primary Sjögren's syndrome treated for two months with evening primrose oilP Oxholm, R Manthorpe, J U Prause, et al.
Annales De Medecine Interne|August 9, 2001
Epidemiology of Sjögren's syndrome, especially its primary formR Manthorpe, L T Jacobsson, Z Kirtava, et al.
Pageof 17

Showing results (81-90 of 166) with videos related to

Sort By:
Pageof 17
Acta Pathologica, Microbiologica, Et Immunologica Scandinavica. Section C, Immunology|February 1, 1983
Autoantibodies in patients with oral lupus erythematosus, lichen planus and leukoplakia. An aid in diagnosisM Schiødt, H Permin, A Wiik, et al.
Acta Ophthalmologica|August 1, 1984
Mucosolvan in the treatment of patients with primary Sjögren's syndrome. Results from a double-blind cross-over investigationR Manthorpe, S H Petersen, J U Prause
Acta Pathologica, Microbiologica, Et Immunologica Scandinavica. Section A, Pathology|March 1, 1985
Langerhans cells in labial minor salivary glands in primary Sjögren's syndromeP Oxholm, R Manthorpe, A Oxholm, et al.
Scandinavian Journal of Rheumatology. Supplement|January 1, 1986
Impaired indomethacin-boosting of the defective natural killer cell activity in patients with primary Sjögren's syndromeB K Pedersen, P Oxholm, R Manthorpe, et al.
Scandinavian Journal of Rheumatology. Supplement|January 1, 1986
Erythrocyte complement C3b receptor (CR1) levels and immune complex-induced manifestations in patients with primary Sjögren's syndromeB S Thomsen, P Oxholm, H Nielsen, et al.
Arthritis and Rheumatism|August 1, 1987
Sjögren's syndrome: comments on the proposed criteria for classificationR Manthorpe, P Oxholm, J N Prause, et al.
Autoimmunity|January 1, 1993
Complement activation in patients with primary Sjögren's syndrome: an indicator of systemic diseaseS Lindgren, B Hansen, A G Sjöholm, et al.
Clinical and Experimental Immunology|January 1, 1986
Interleukin 2 augmentation of the defective natural killer cell activity in patients with primary Sjögren's syndromeB K Pedersen, P Oxholm, R Manthorpe, et al.
Scandinavian Journal of Rheumatology|January 1, 1986
Patients with primary Sjögren's syndrome treated for two months with evening primrose oilP Oxholm, R Manthorpe, J U Prause, et al.
Annales De Medecine Interne|August 9, 2001
Epidemiology of Sjögren's syndrome, especially its primary formR Manthorpe, L T Jacobsson, Z Kirtava, et al.
Pageof 17